Food and Drug Administration

Nonprescription Drugs Advisory Committee

September 19, 2002

Briefing Information

Index  pdf

Section I: Overview and Federal Register Documents

Section I Index  pdf

Overview of the September 19 and 20, 2002 NDAC Meeting  pdf

Establishment of a Monograph for OTC Internal Analgesic, Antipyretic and Antirheumatic products (Panel Report or ANPR)  pdf

Internal Analgesic, Antipyretic and Antirheumatic Products for over-The -Counter Human Use; Tentative Final Monograph  pdf

Over-The-Counter Drug products Containing Analgesic/Antipyretic Active Ingredients for Internal Use; Required Alcohol Warning (Notice of Proposed Rulemaking)  pdf

Over-The-Counter Drug products Containing Analgesic/Antipyretic Active Ingredients for Internal Use; Required Alcohol Warning (Final Rule)  pdf

Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-The-Counter Human Use; Final Rule for Professional Labeling of Aspirin, Buffered Aspirin, and Aspirin in Combination with Antacid Drug Products  pdf

Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-The- Counter Human Use; Proposed Amendment of the Tentative Final Monograph, and Related Labeling  pdf

Section II:  Acetaminophen Reviews

Section II Index  pdf

Archeological Review of the Regulatory history of OTC Single Ingredient Acetaminophen  pdf

History Supporting Documents  pdf

Acetaminophen-PK/Metabolism  pdf

Acetaminophen - Containing Products-Hepatotoxicity  pdf

Acetaminophen - Utilization Data  pdf

Acetaminophen - Epidemiology of Acetaminophen-related Overdose - National Mortality Data  pdf

Review of Acetaminophen Poisoning Exposures in Toxic Exposure Surveillance System (TESS)  pdf

Review of Adult and Adolescents Exposure Data on Acetaminophen-containing Products from Two Regional Poison Control Centers  pdf

Acetaminophen Overdose Reference Articles  pdf

Emerging Trends in Acute Liver Failure in U.S. - Abstract  pdf

Section III: NSAID/Aspirin Reviews

Section III Index  pdf

Literature Search Submitted in Preparation for the September 2002 NDAC Meeting  pdf

Appendix I  pdf

NSAID Renal Review  pdf

Renal Toxicity References (6)  pdf

Aspirin - GI Bleed  pdf

NSAID - GI Bleed  pdf

NSAID/ASA GI Bleed References (5)  pdf

Section IV: Safety Reports

 Acetaminophen (APAP) Safety Reports   doc   htm   pdf

Acetaminophen (APAP) Safety Reports Index  xls

Aspirin Safety Reports Index  doc  pdf

OTC Aspirin Safety Reports, Part I    pdf

OTC Aspirin Safety Reports, Part II   pdf

OTC Aspirin Safety Reports, Part III   pdf

Ibuprophen Safety Reports Index  doc  pdf

OTC NSAID:  Ibuprophen Safety Reports, Part I   pdf

OTC NSAID:  Ibuprophen Safety Reports, Part II   pdf

Ketoprofen Safety Reports Index  doc  htm  pdf

OTC NSAID: Ketoprofen Safety Reports   pdf

Naproxen Safety Reports Index  doc  htm  pdf

OTC NSAID: Naproxen Safety Reports, Part I   pdf

OTC NSAID: Naproxen Safety Reports, Part II   pdf

Industry Backgrounders

Acetaminophen, McNeil Consumer & Specialty Pharmaceuticals  doc  htm  pdf

Monograph Analgesic Products, Bayer Consumer Care Division  pdf

Safety Issues Related to the Use of Acetaminophen, Pfizer, Inc.  pdf

American Association of Poison Control Centers (AAPCC) Toxic Exposure Surveillance System (TESS), The Procter & Gamble Co.  doc  htm  pdf

Current OTC Analgesic Labeling  pdf